Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current standards for dialysis adequacy

M Keen1, G Schulman

  • 1AMGEN, Inc, Thousand Oaks, CA, USA.

Advances in Renal Replacement Therapy
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A young man with 20 years of nephrotic range proteinuria without loss of renal function.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Focus on imaging at the American Society of Nephrology annual meeting.

Radiology·2001
Same author

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

JAMA·2001
Same author

The role of hemodialysis and peritoneal dialysis for the early initiation of dialysis.

Blood purification·2001
Same author

Interdialytic weight gain and dry weight.

Blood purification·2001
Same author

Indications for vancomycin in dialysis patients.

Seminars in dialysis·2000

Optimizing hemodialysis dosage is crucial for patient outcomes. Higher hemodialysis levels, as measured by urea kinetic modeling, are linked to reduced morbidity and mortality in patients undergoing kidney dialysis.

Area of Science:

  • Nephrology
  • Clinical Trials
  • Renal Replacement Therapy

Background:

  • Inadequate hemodialysis dosage is linked to increased patient morbidity and mortality.
  • Retrospective studies suggest higher hemodialysis levels may improve outcomes.
  • The National Cooperative Dialysis Study (NCDS) established urea kinetic modeling for quantifying dialysis dose.

Purpose of the Study:

  • To review the application and limitations of urea kinetic modeling based on NCDS results.
  • To discuss modifications for urea kinetic modeling, including urea rebound.
  • To initiate the HEMO Study assessing newer membranes and higher dialysis levels in an older, comorbid population.

Main Methods:

  • Review of the National Cooperative Dialysis Study (NCDS) findings.

Related Experiment Videos

  • Discussion of urea kinetic modeling principles and limitations.
  • Initiation of the 5-year, multicenter, prospective HEMO Study.

    • Main Results:

    • The NCDS identified a threshold for hemodialysis dose below which adverse events occurred.
    • Urea kinetic modeling is a validated method for quantifying hemodialysis dose.
    • The HEMO Study aims to evaluate newer dialysis technologies and higher doses.

    Conclusions:

    • Hemodialysis dosage significantly impacts patient morbidity and mortality.
    • Urea kinetic modeling is a key tool for optimizing dialysis prescription.
    • Ongoing research, like the HEMO Study, is vital for advancing hemodialysis treatment.